India  

Covid-19: Pfizer says vaccine 95% effective in the final trials|Oneindia News

Video Credit: Oneindia - Duration: 02:20s - Published
Covid-19: Pfizer says vaccine 95% effective in the final trials|Oneindia News

Covid-19: Pfizer says vaccine 95% effective in the final trials|Oneindia News

The Indian Army will have upgraded living quarters in Eastern Ladakh this winter.

The region here receives over 40 feet of snowfall after Nov each year and the temp here falls to minus 30 to minus 40 deg celcius.

Pharmaceutical giant Pfizer on Wednesday said that its COVID-19 vaccine candidate was found to be 95 per cent effective in the final analysis of the Phase 3 trial.

Within two days of government formation in Bihar a controversy has erupted over the appointment of corruption-accused Janata Dal United (JDU) legislator, Mewalal Choudhary, as the Education Minister.After Kapil Sibal now, P Chidambaram has said that the Bihar election and by-poll results show that the Congress has no organisational presence on the ground or has weakened considerably.

#Pfizer #CoronavirusPandemic #NitishKumar


You Might Like


Related videos from verified sources

Moderna seeks U.S., EU vaccine authorization [Video]

Moderna seeks U.S., EU vaccine authorization

[NFA] Moderna will apply for U.S. and European emergency-use authorization for its COVID-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious..

Credit: Reuters - Politics     Duration: 01:59Published
Allegheny Co. Executive Fitzgerald Part Of COVID Vaccine Trial [Video]

Allegheny Co. Executive Fitzgerald Part Of COVID Vaccine Trial

Allegheny County Executive Rich Fitzgerald tweeted that he believed he was part of the Moderna COVID-19 vaccine trial that received the actual vaccine.

Credit: KDKA CBS 2 Pittsburgh     Duration: 00:28Published
Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval [Video]

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval

Moderna to Submit COVID-19 Vaccine for FDA Regulatory Approval. Moderna will submit its coronavirus vaccine on Nov. 30. It is the second drugmaker to ask the FDA for emergency use..

Credit: Wibbitz Top Stories     Duration: 01:03Published